APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS

Detalhes bibliográficos
Autor(a) principal: Aoun Moustapha, Nathalia
Data de Publicação: 2020
Outros Autores: Negrão Multari , Júlia, Santos , Ed Wilson, Tellaroli, Giovanna, Hoffman Bueno Magdanelo, Esther Ligia Laura
Tipo de documento: preprint
Idioma: por
Título da fonte: SciELO Preprints
Texto Completo: https://preprints.scielo.org/index.php/scielo/preprint/view/1463
Resumo: The canine visceral leishmaniasis (CVL) is a zoonosis extremely important for public health, of worldwide relevance, with 90% of the cases registered in Brazil. It´s caused by the protozoan from the genus Leishmania and its main host is the domestic dog. For the successful transmission, it must have the presence of the vector, a hematophagous mosquito from genus Lutyzomia. The diagnostic from the disease is extremely difficult, seen that 60% to 80% of the seropositive animals are asymptomatic and the clinical manifestations are very nonspecific. After changes made by the Health Ministry, it actually is permitted to realize the treatment of the positive animals to CVL, in which the most accepted medicament is Miltefosine.  Yet, independent of the treatment, the best method against CVL is prevention. In the present job was produced a questionnaire through the platform Google Forms with 14 questions encompassing the Leishmaniasis. Were collected 65 answers veterinarians of different ages and states of Brazil.  80% of vets said to indicate the treatment of the animal in cases of leishmaniasis confirmed, while 3.08% still indicate euthanasia. Although not recommended, the use of amphotericin B and pentavalent antimonials is still seen in the treatment protocols, however, the majority (75.4%) opts for the use of Miltefosina, recommended. Vaccination, although accepted by most veterinarians (95.38%), is still a little-used practice due to the low product availability in clinics, just 47.69% have in the veterinary clinic. Among veterinarians, 95.4% indicate the use of 4% deltamethrin collars as prevention. A good performance by the veterinarian is of paramount importance for the control effect of VL.
id SCI-1_9028618bbcf9b60ef9054aff1078b035
oai_identifier_str oai:ops.preprints.scielo.org:preprint/1463
network_acronym_str SCI-1
network_name_str SciELO Preprints
repository_id_str
spelling APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORSENFOQUE DE LA LEISHMANIASIS VISCERAL CANINA (LVC) POR DOCTORES VETERINARIOSABORDAGEM DA LEISHMANIOSE VISCERAL CANINA (LVC) POR MÉDICOS VETERINÁRIOSleishmaniose visceral caninaBrasiltratamentoprevençãocontrolecanine visceral leishmaniasisBraziltreatmentpreventioncontrolleishmaniasis visceral caninaBrasiltratamientoprevencióncontrolarThe canine visceral leishmaniasis (CVL) is a zoonosis extremely important for public health, of worldwide relevance, with 90% of the cases registered in Brazil. It´s caused by the protozoan from the genus Leishmania and its main host is the domestic dog. For the successful transmission, it must have the presence of the vector, a hematophagous mosquito from genus Lutyzomia. The diagnostic from the disease is extremely difficult, seen that 60% to 80% of the seropositive animals are asymptomatic and the clinical manifestations are very nonspecific. After changes made by the Health Ministry, it actually is permitted to realize the treatment of the positive animals to CVL, in which the most accepted medicament is Miltefosine.  Yet, independent of the treatment, the best method against CVL is prevention. In the present job was produced a questionnaire through the platform Google Forms with 14 questions encompassing the Leishmaniasis. Were collected 65 answers veterinarians of different ages and states of Brazil.  80% of vets said to indicate the treatment of the animal in cases of leishmaniasis confirmed, while 3.08% still indicate euthanasia. Although not recommended, the use of amphotericin B and pentavalent antimonials is still seen in the treatment protocols, however, the majority (75.4%) opts for the use of Miltefosina, recommended. Vaccination, although accepted by most veterinarians (95.38%), is still a little-used practice due to the low product availability in clinics, just 47.69% have in the veterinary clinic. Among veterinarians, 95.4% indicate the use of 4% deltamethrin collars as prevention. A good performance by the veterinarian is of paramount importance for the control effect of VL.La leishmaniasis visceral canina (LVC) es una zoonosis de extrema importancia en la salud pública, en todo el mundo, con el 90% de los casos registrados en Brasil.  Es causada por el protozoario género Leishmania y su principal huésped es el perro doméstico y, para que se produzca la transmisión, es obligatoria la presencia del vector, el mosquito hematófago género Lutzomyia. El diagnóstico de la enfermedad es bastante difícil, ya que del 60 al 80% de los animales seropositivos son asintomáticos y las manifestaciones clínicas son muy inespecíficas.  Después de los cambios realizados por el Ministerio de Salud, actualmente está permitido llevar a cabo el tratamiento de animales positivos para LVC, en el que el medicamento más aceptado es Miltefosina, sin embargo, independientemente del tratamiento, el mejor método contra LVC es la prevención.  En el presente trabajo, se produjo un cuestionario a través de la plataforma Google Forms con 14 preguntas que cubren la leishmaniasis.  Se recogieron 65 respuestas de veterinarios de diferentes edades y estados de Brasil.  El 80% de los veterinarios dijeron que indicaban el tratamiento del animal en caso de leishmaniasis confirmada, mientras que el 3.08% todavía indica eutanasia.  Aunque no se recomienda, aún se observa el uso de anfotericina B y antimoniales pentavalentes en los protocolos de tratamiento, sin embargo, la mayoría (75.4%) opta por el uso de miltefosina, se recomienda.  La vacunación, aunque aceptada por la mayoría de los veterinarios (95.38%), todavía es una práctica poco utilizada debido a la baja disponibilidad del producto en las clínicas, solo el 47.69% lo tiene en la clínica veterinaria.  Entre los veterinarios, el 95.4% indica el uso de collares de deltametrina al 4% como prevención.  Un buen desempeño por parte del veterinario es de suma importancia para el efecto de control de VL.A Leishmaniose visceral canina (LVC) é uma zoonose de extrema importância na saúde pública, de distribuição mundial, com 90% dos casos registrados no Brasil. É causada pelo protozoário gênero Leishmania e tem como principal hospedeiro o cão doméstico. Para que ocorra a transmissão, é obrigatória a presença do vetor, mosquito hematófago Lutzomyia sp. O diagnóstico da doença é bastante difícil, já que 60 a 80% dos animais soropositivos são assintomáticos e as manifestações clínicas são muito inespecíficas. Após mudanças realizadas pelo Ministério da Saúde, atualmente é permitido realizar o tratamento dos animais positivos para LVC, no qual o medicamento mais aceito é a miltefosina, porém, independente do tratamento, o melhor método contra a LVC é a prevenção. No presente trabalho foi produzido um questionário através da plataforma Google Forms com 14 perguntas englobando a Leishmaniose. Foram coletadas 65 respostas de médicos veterinários de diferentes idades e estados do Brasil.  80% dos veterinários disseram indicar o tratamento do animal em caso de leishmaniose confirmada, enquanto 3,08% ainda indicam a eutanásia. Embora não recomendados, ainda se nota o uso de anfotericina B e antimoniais pentavalentes nos protocolos de tratamento, porém a maioria (75,4%) opta pelo uso da miltefosina, recomendada. A vacinação, embora aceita pela maioria dos veterinários (95,38%), ainda é uma prática pouco utilizada devido à baixa disponibilidade do produto nas clínicas, somente 47,69% tem no consultório. Dentre os veterinários, 95,4% indicam o uso de coleiras de deltametrina 4% como prevenção. Uma boa atuação do médico veterinário é de suma importância para o efeito controle da LV.SciELO PreprintsSciELO PreprintsSciELO Preprints2020-11-16info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/146310.1590/SciELOPreprints.1463porhttps://preprints.scielo.org/index.php/scielo/article/view/1463/2319Copyright (c) 2020 Nathalia Aoun Moustapha, Júlia Negrão Multari , Ed Wilson Santos , Giovanna Tellaroli, Esther Ligia Laura Hoffman Bueno Magdanelohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAoun Moustapha, NathaliaNegrão Multari , Júlia Santos , Ed WilsonTellaroli, GiovannaHoffman Bueno Magdanelo, Esther Ligia Laurareponame:SciELO Preprintsinstname:SciELOinstacron:SCI2020-11-12T15:00:11Zoai:ops.preprints.scielo.org:preprint/1463Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2020-11-12T15:00:11SciELO Preprints - SciELOfalse
dc.title.none.fl_str_mv APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
ENFOQUE DE LA LEISHMANIASIS VISCERAL CANINA (LVC) POR DOCTORES VETERINARIOS
ABORDAGEM DA LEISHMANIOSE VISCERAL CANINA (LVC) POR MÉDICOS VETERINÁRIOS
title APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
spellingShingle APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
Aoun Moustapha, Nathalia
leishmaniose visceral canina
Brasil
tratamento
prevenção
controle
canine visceral leishmaniasis
Brazil
treatment
prevention
control
leishmaniasis visceral canina
Brasil
tratamiento
prevención
controlar
title_short APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
title_full APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
title_fullStr APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
title_full_unstemmed APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
title_sort APPROACH TO CANINE VISCERAL LEISHMANIASIS (CVL) BY VETERINARY DOCTORS
author Aoun Moustapha, Nathalia
author_facet Aoun Moustapha, Nathalia
Negrão Multari , Júlia
Santos , Ed Wilson
Tellaroli, Giovanna
Hoffman Bueno Magdanelo, Esther Ligia Laura
author_role author
author2 Negrão Multari , Júlia
Santos , Ed Wilson
Tellaroli, Giovanna
Hoffman Bueno Magdanelo, Esther Ligia Laura
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Aoun Moustapha, Nathalia
Negrão Multari , Júlia
Santos , Ed Wilson
Tellaroli, Giovanna
Hoffman Bueno Magdanelo, Esther Ligia Laura
dc.subject.por.fl_str_mv leishmaniose visceral canina
Brasil
tratamento
prevenção
controle
canine visceral leishmaniasis
Brazil
treatment
prevention
control
leishmaniasis visceral canina
Brasil
tratamiento
prevención
controlar
topic leishmaniose visceral canina
Brasil
tratamento
prevenção
controle
canine visceral leishmaniasis
Brazil
treatment
prevention
control
leishmaniasis visceral canina
Brasil
tratamiento
prevención
controlar
description The canine visceral leishmaniasis (CVL) is a zoonosis extremely important for public health, of worldwide relevance, with 90% of the cases registered in Brazil. It´s caused by the protozoan from the genus Leishmania and its main host is the domestic dog. For the successful transmission, it must have the presence of the vector, a hematophagous mosquito from genus Lutyzomia. The diagnostic from the disease is extremely difficult, seen that 60% to 80% of the seropositive animals are asymptomatic and the clinical manifestations are very nonspecific. After changes made by the Health Ministry, it actually is permitted to realize the treatment of the positive animals to CVL, in which the most accepted medicament is Miltefosine.  Yet, independent of the treatment, the best method against CVL is prevention. In the present job was produced a questionnaire through the platform Google Forms with 14 questions encompassing the Leishmaniasis. Were collected 65 answers veterinarians of different ages and states of Brazil.  80% of vets said to indicate the treatment of the animal in cases of leishmaniasis confirmed, while 3.08% still indicate euthanasia. Although not recommended, the use of amphotericin B and pentavalent antimonials is still seen in the treatment protocols, however, the majority (75.4%) opts for the use of Miltefosina, recommended. Vaccination, although accepted by most veterinarians (95.38%), is still a little-used practice due to the low product availability in clinics, just 47.69% have in the veterinary clinic. Among veterinarians, 95.4% indicate the use of 4% deltamethrin collars as prevention. A good performance by the veterinarian is of paramount importance for the control effect of VL.
publishDate 2020
dc.date.none.fl_str_mv 2020-11-16
dc.type.driver.fl_str_mv info:eu-repo/semantics/preprint
info:eu-repo/semantics/publishedVersion
format preprint
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://preprints.scielo.org/index.php/scielo/preprint/view/1463
10.1590/SciELOPreprints.1463
url https://preprints.scielo.org/index.php/scielo/preprint/view/1463
identifier_str_mv 10.1590/SciELOPreprints.1463
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://preprints.scielo.org/index.php/scielo/article/view/1463/2319
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
publisher.none.fl_str_mv SciELO Preprints
SciELO Preprints
SciELO Preprints
dc.source.none.fl_str_mv reponame:SciELO Preprints
instname:SciELO
instacron:SCI
instname_str SciELO
instacron_str SCI
institution SCI
reponame_str SciELO Preprints
collection SciELO Preprints
repository.name.fl_str_mv SciELO Preprints - SciELO
repository.mail.fl_str_mv scielo.submission@scielo.org
_version_ 1797047820748849152